Articles tagged with Lysates
Researchers at TUM develop NTVE, a process that uses virus-like particles to shuttle messenger RNA out of living cells, allowing for repeated sampling and analysis. This enables precise monitoring of stem cell development and potential applications in cell therapies and tumor research.
A new immunotherapy approach using nanoparticles has shown promising results in extending the survival of mice with triple negative breast cancer. The treatment, which incorporates oxidized tumor cell lysates, triggered a stronger immune response and led to complete remission in two-thirds of treated mice.
Researchers have developed a platelet-rich plasma lysate that, when teamed with antibiotics, can eradicate bacterial biofilms common in joint infections. The therapy has shown great results in horses and may also be applied to humans and dogs.
Researchers developed a melanin-enhanced cancer immunotherapy technique using a transdermal patch that promotes the systemic immune response against melanoma. The patch is applied via a skin patch and triggers an immune response, allowing the body's immune system to remember and respond to the presence of melanoma cells.